Smartphone app for young people with type 2 diabetes
Tests a phone app that shows glucose and exercise data in young people with diabetes.
Plain-language title generated from the registry record
Registry title: Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
Key facts
- Where
- Pittsburgh, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 14 and 26 years old?
Source: NCT06375460, who can take part
Where in United States
- UPMC Children's Hospital of PittsburghPittsburgh, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Pittsburgh
- Trial code
- NCT06375460
- Record updated
- 7 October 2026
- Original description
The goal of this clinical trial is to learn if a new smartphone app that pairs glucose and exercise data will help adolescents and young adults with type 2 diabetes improve glycemic control. It will also study how changes in glycemic control are maintained over time. The main questions it aims to answer are:Read full original descriptionShow less
Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
The goal of this clinical trial is to learn if a new smartphone app that pairs glucose and exercise data will help adolescents and young adults with type 2 diabetes improve glycemic control. It will also study how changes in glycemic control are maintained over time. The main questions it aims to answer are:
* Does using the app help with short-term glycemic control? * Does using the app help with longer-term glycemic control? * Does using the app help increase physical activity?
Participants will:
* Wear a continuous glucose monitoring device for 6 months * Wear a physical activity tracker for 6 months * Use the study smartphone app for 6 months * Complete 3 in-person study visits with fasting blood draws * Report dietary intake intermittently throughout the study
Inclusion: type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes; English-speaking (app in English).
Exclusion: Current or previously diagnosed eating disorder; Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management; Current pregnancy; Hydroxyurea use (CGM sensor inaccuracies).